Amyotrophic lateral sclerosis (ALS) is a rapidly progressing, as yet incurable neurodegenerative disease that poses considerable medical, therapeutic and social challenges. Despite its comparatively low prevalence, ALS represents a central issue in neurological research due to its complexity and severity. New findings on molecular pathogenesis, the role of genetic factors and the development of innovative therapeutic strategies open up promising prospects for diagnosis, treatment and care.
Autoren
- Tanja Schliebe
Publikation
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- "Survey of Health, Ageing and Retirement in Europe" (SHARE)
Analysis of polypharmacy in ≥65-year-olds
- New perspectives for clinics and research
Ageing, cellular senescence and Parkinson’s disease
- From early intervention to individualization
The new guidelines at a glance
- Artificial intelligence
Dr. ChatGPT: Large language models in everyday clinical practice
- COPD therapy
Drug therapy – Update 2025
- Focus on prevention
Colorectal cancer screening – an update
- From symptom to diagnosis
Oncology – Thymoma
- Shared decision making